Critical R&D investments, rigorous clinical trials, access to capital, ongoing regulatory hurdles—these are only some of the key challenges Life Science companies face. At Woodruff Sawyer, we offer customized solutions to tackle these and other unique industry risks, through the most thorough discovery process in the industry.
Dedicated to the Life Sciences industry for almost 30 years, we’re more than an insurance broker; we’re a trusted business advisor to some of the world’s most innovative Life Science companies, with one of the largest client portfolios in the industry. From product and clinical trials liability, to supply chain risk, D&O liability, and employee benefits, we are your advocate to protect all aspects of your business, in every part of the world where you operate.
Safeguarding Science By Sector
- Medical Device
- Digital Health
- Supply Chain Providers
Priya Huskins is on the scene at the Delaware Supreme Court hearing the case argued against the 2018 Sciabacucchi v. Salzberg decision. These are her insights.
In this post, we’ll look at how to assess cyber exposure for a life science company in order to make more informed decisions about this risk area, and the consequent need (or lack thereof) for cyber coverage.